<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04102072</url>
  </required_header>
  <id_info>
    <org_study_id>COMMENT</org_study_id>
    <nct_id>NCT04102072</nct_id>
  </id_info>
  <brief_title>The Consistency of Cardiac Output Measurements by Different Methods in VA-ECMO Patients</brief_title>
  <official_title>The Consistency of Cardiac Output Measurements by Different Methods in VA-ECMO Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective：

        1. To evaluate the consistency of cardiac output measured by different hemodynamic
           monitoring methods in patients with VA-ECMO

        2. To evaluate whether different hemodynamic monitoring methods can accurately detect the
           trend of cardiac output changes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been used for profound
      cardiogenic shock to bridge to decision,ventricular assist devices,or transplant.Close
      monitoring of cardiac output, especially in patients before and after intervention (such as
      volume expansion, diuresis, vasoconstriction, vasodilation therapy), can help to adjust the
      treatment strategy. Hemodynamic monitoring in ECMO patients requires familiarity with the
      underlying pathophysiology and circulatory mechanics of extracorporeal flow.Limited to the
      actual clinical situation of patients, one or two hemodynamic monitoring methods may be
      accepted. Is there consistency between different hemodynamic monitoring results? And whether
      hemodynamic monitoring can accurately detect the changes of these parameters before and after
      intervention is an important issue in clinical practice. This study will provide important
      reference for VA-ECMO patients how to choose appropriate hemodynamic monitoring tools and how
      to interpret the results of hemodynamic monitoring.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 23, 2019</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline Cardiac Output measurement</measure>
    <time_frame>within1 minute at baseline position</time_frame>
    <description>Cardiac Output measured at baseline position（ in a supine position with the head elevated to 15° for baseline measurements ）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Output measurement afterTrendelenburg Maneuver</measure>
    <time_frame>1 minute after starting Trendelenburg Maneuver</time_frame>
    <description>Cardiac Output measured after Trendelenburg Maneuver</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Output measurement after Dobutamine stress test</measure>
    <time_frame>5 minutes after dobutamine stress test</time_frame>
    <description>Cardiac Output measured after dobutamine stress test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Extracorporeal Membrane Oxygenation</condition>
  <arm_group>
    <arm_group_label>Trendelenburg Maneuver</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Trendelenburg position is a common treatment in medicine.It is used either as a diagnostic tool to assess fluid loading response or as a therapeutic maneuver pending fluid resuscitation.With the advantage of autotransfusion readily available,the Trendelenburg position is used for expected instantaneous effect on cardiovascular performance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dobutamine stress test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dobutamine is a selective beta 1 receptor agonist. It [&lt;10 ug/(kg.min)] can effectively increase myocardial contractility.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Trendelenburg Maneuver</intervention_name>
    <description>In the Trendelenburg position, the body is laid supine with the feet higher than the head by 15-30 degrees. The venous return increases in the trendelenburg position which in turn increases the stroke volume.</description>
    <arm_group_label>Trendelenburg Maneuver</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>dobutamine stress test</intervention_name>
    <description>Dobutamine was infused intravenously at the initial dose of 2.5 ug/kg/min. Echocardiography was performed after 5-10 minutes of continuous infusion, and hemodynamic data were recorded.</description>
    <arm_group_label>dobutamine stress test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. cardiac surgery

          2. treatment with VA-ECMO

          3. mechanical ventilation

          4. hemodynamic monitoring according to patient's condition (PAC, Flotrac,
             echocardiography)

        Exclusion Criteria:

          1. age &lt; 18

          2. cardiac arrhythmia

          3. moderate to severe aortic, mitral and tricuspid regurgitation

          4. active hemorrhage

          5. IABP

          6. spontaneous triggering of the ventilator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhe Luo, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guo-wei Tu, Doctor</last_name>
    <phone>86-021-64041990</phone>
    <email>tu.guowei@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jun-yi Hou, Doctor</last_name>
    <phone>86-021-64041990</phone>
    <email>hou.junyi@zs-hospital.sh.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan hospital, Fudan university</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guo-wei Tu, Doctor</last_name>
      <phone>86-021-64041990</phone>
      <email>tu.guowei@zs-hospital.sh.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 10, 2019</study_first_submitted>
  <study_first_submitted_qc>September 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2019</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pulmonary artery catheter</keyword>
  <keyword>echocardiography</keyword>
  <keyword>fluid responsiveness</keyword>
  <keyword>extracorporeal membrane oxygenation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dobutamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

